<DOC>
	<DOCNO>NCT00095147</DOCNO>
	<brief_summary>The purpose clinical research study learn Abatacept Infliximab combination Methotrexate demonstrate great reduction disease activity placebo .</brief_summary>
	<brief_title>Abatacept Infliximab Combination With Methotrexate Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Diagnosis Rheumatoid Arthritis At least 3 month prior treatment Methotrexate ( MTX ) At least 10 swollen joint 12 tender joint CReactive Protein least 1 mg/dl Washout required disease modify antirheumatic drug ( DMARDS ) participant fail 3 DMARDs participant previously treat approved biologic drug History cancer last 5 year Severe recurrent bacterial infection Any previous current medical condition contraindication use TNF block agent Women Child Bearing Potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>